Astellas Pharma Inc (ALPMY)
9.85
-0.23
(-2.28%)
USD |
OTCM |
Dec 16, 16:00
Astellas Pharma Profit Margin (Quarterly): 7.95% for June 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.83% |
| Pfizer Inc | 25.22% |
| Nxera Pharma Co Ltd | 12.95% |
| PeptiDream Inc | -5.57% |
| Healios KK | -107.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.97% |
| Return on Assets | 0.46% |
| Return on Invested Capital | 0.66% |
| Gross Profit Margin (Quarterly) | 80.74% |
| Operating Margin (Quarterly) | 10.11% |
| Return on Net Operating Assets | 0.58% |